Dasgip

DASGIP GmbH develops and manufactures technologically-superior parallel bioreactor systems designed for the lab-scale cultivation of bacterial, mammalian and human cells.

Process engineers, researchers and product development specialists who work with biotechnology processes rely on DASGIP parallel bioreactor systems to drive their projects forward, thus benefiting from increased cell and media productivity, reproducible and scalable results, and shortened innovation cycles.